Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

COL4A2 Gene Porencephaly Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين COL4A2 لتكهف الدماغ من النوع 2 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي

تحليل جيني متقدم بتقنية التسلسل الجيني من الجيل التالي (NGS) للكشف عن طفرات جين COL4A2 المسببة لتكهف الدماغ من النوع 2. يُقدم التشخيص بدقة 99.9% عبر مختبر معتمد ISO. يشمل استشارة وراثية قبل الاختبار، وسحب عينة منزلي فاخر، وإرشاد بعد النتائج. مطابق لقانون الإمارات رقم 41 لسنة 2024 وقانون CDS للقُصّر. ضمان خصوصية البيانات بموجب PDPL الإماراتي.

99.9% Diagnostic Sensitivity – ISO 9001:2015 Certified Processing
Premium Hospital‑Grade Home Collection – VIP Mobile Phlebotomy, 8 AM‑11 PM
Telephonic Post‑Test Clinical Guidance by Genetic Experts
Direct Insurance Billing Verification via WhatsApp +971 54 548 8731
DHA‑Endorsed Genetic Test

Price: 2,800 AED

Turnaround: 3‑4 Weeks

Sample: Blood / Extracted DNA / FTA Card

📞 Book Collection: +971 54 548 8731 💬 WhatsApp: Verify Insurance Now

Overview of COL4A2 Gene Testing for Porencephaly Type 2

The COL4A2 NGS Test identifies pathogenic variants in the collagen type IV alpha 2 chain gene linked to familial porencephaly and cerebrovascular malformations. This high-resolution sequencing covers all exons and intron‑exon boundaries, delivering definitive molecular diagnosis for affected individuals, at‑risk relatives, and preconception counselling. In parallel, يوفر الاختبار تحديدًا دقيقًا للطفرة الجينية المسببة لتكهف الدماغ العائلي, ensuring tailored neurological surveillance and early intervention planning in the UAE healthcare ecosystem.

Feature Our Test (VegaGene DHA Genomic Lab) Closest Alternative (Standard Lab)
Technology Next‑Generation Sequencing (NGS) with full bioinformatics pipeline Limited gene panel or single‑gene Sanger
Coverage All exons + 20 bp flanking introns, CNV detection Selected hotspot regions only
Turnaround 3‑4 weeks 4‑6 weeks
Pre‑test Genetic Counselling Included (pedigree charting, risk assessment) Often not provided
Post‑test Clinical Guidance Telephonic call with neurologist‑geneticist Written report only

Physician Insight & Safety Protocol

“As a neurologist deeply involved in neurogenetic care, I understand the uncertainty families face. The COL4A2 test provides a molecular anchor for accurate prognosis and surveillance. However, always correlate the result with imaging and clinical phenotype—no single test replaces a comprehensive neurological evaluation. Please continue all prescribed anti‑epileptic or anti‑coagulant medications unless your physician advises otherwise.”

— Dr. PRABHAKAR REDDY, Consultant Neurologist & Geneticist, DHA License: 61713011

Medication Warning

Do not discontinue prescribed medication (e.g., anticonvulsants, antiplatelet agents) without consulting your doctor.

Exclusion Criteria & ER Red Flags

  • Acute neurological emergency: Sudden severe headache, seizure, loss of consciousness – seek emergency care, not elective testing.
  • Pending neuroimaging: If MRI/CT shows acute intracranial hemorrhage or stroke, delay genetic testing until stabilized.
  • Unable to provide consent: Minors require legal guardian consent compliant with UAE CDS Law 2026.
  • Unstable psychiatric condition: Should be addressed prior to elective genetic counselling.
  • Red Flag Symptoms (call 998): Acute hemiparesis, thunderclap headache, febrile seizure with altered consciousness.

All home collections are performed by DHA‑licensed phlebotomists with full infection control. If you experience any distress during sample collection, inform the staff immediately.

Patient FAQ & Clinical Guidance

What is the clinical utility of COL4A2 genetic testing for porencephaly type 2 in children?

Snapshot Answer: This test confirms a definitive molecular diagnosis of COL4A2-related porencephaly, guiding neurologists in predicting recurrence risk, planning surveillance for stroke-like events, and offering targeted genetic counselling to families.

اجابة سريعة: يؤكد هذا الاختبار التشخيص الجزيئي الحاسم لطفرة جين COL4A2 المسببة لتكهف الدماغ، مما يساعد أطباء الأعصاب على تقدير خطر التكرار لدى الأقارب والتخطيط لمراقبة الأوعية الدموية الدماغية.

How does home sample collection work for this test, and is it covered by insurance in UAE?

Snapshot Answer: Our DHA‑licensed phlebotomist arrives at your doorstep between 8 AM‑11 PM, collects a blood sample under strict cold‑chain protocols, and delivers it to our ISO‑certified lab; we verify insurance directly via WhatsApp.

اجابة سريعة: يصل أخصائي سحب الدم المرخص من هيئة الصحة بدبي إلى منزلك بين 8 صباحًا و11 مساءً، ويسحب العينة بطريقة معقمة وفق سلسلة تبريد دقيقة، مع التحقق من تغطية التأمين مباشرة عبر الواتساب.

What do I need to prepare before giving the sample for the COL4A2?

Snapshot Answer: No fasting required; bring a list of all current medications and the completed clinical history form provided after booking; a genetic counselling session will precede the sampling to document family history.

اجابة سريعة: لا يشترط الصيام؛ يجب إحضار قائمة بجميع الأدوية الحالية ونموذج التاريخ السريري المكتمل، وستسبق جلسة استشارة وراثية عملية السحب لتوثيق شجرة العائلة.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians